Payer PolicyActive
MED.00103 Automated Evacuation of Meibomian Gland
ANTHEM-MED.00103
Anthem
Effective: October 1, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses automated meibomian gland evacuation devices that apply localized heat with intermittent/graded pressure to the eyelids (e.g., LipiFlow) and associated tear film imaging for treating meibomian gland dysfunction. Anthem deems these services investigational/experimental and not medically necessary; therefore, they are not covered. There are no covered indications or exceptions under this policy, and tear film imaging performed in conjunction with these devices is also non-covered.
Coverage Criteria Preview
Key requirements from the full policy
"The use of an automated evacuation device using heat and intermittent pressure, and associated tear film imaging, is consideredinvestigational and not medically necessaryfor the treatment of meibom..."
Sign up to see full coverage criteria, indications, and limitations.